Annual ROE
-110.17%
+87.00%+44.12%
December 31, 2023
Summary
- As of February 8, 2025, TPST annual return on equity is -110.17%, with the most recent change of +87.00% (+44.12%) on December 31, 2023.
- During the last 3 years, TPST annual ROE has fallen by -138.09% (-494.59%).
- TPST annual ROE is now -494.59% below its all-time high of 27.92%, reached on December 31, 2020.
Performance
TPST ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-187.44%
+13.66%+6.79%
September 30, 2024
Summary
- As of February 8, 2025, TPST quarterly return on equity is -187.44%, with the most recent change of +13.66% (+6.79%) on September 30, 2024.
- Over the past year, TPST quarterly ROE has increased by +190.77% (+50.44%).
- TPST quarterly ROE is now -187.44% below its all-time high of 214.36%, reached on June 30, 2021.
Performance
TPST Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TPST ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.1% | +50.4% |
| 3 y3 years | -494.6% | +50.4% |
| 5 y5 years | -494.6% | +50.4% |
TPST ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.6% | +44.1% | -182.1% | +50.4% |
| 5 y | 5-year | -494.6% | +44.1% | -187.4% | +50.4% |
| alltime | all time | -494.6% | +44.1% | -187.4% | +50.4% |
Tempest Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -187.44%(-6.8%) |
| Jun 2024 | - | -201.10%(-13.5%) |
| Mar 2024 | - | -232.39%(-18.1%) |
| Dec 2023 | -110.17%(-44.1%) | -283.87%(-24.9%) |
| Sep 2023 | - | -378.21%(+73.0%) |
| Jun 2023 | - | -218.64%(+42.4%) |
| Mar 2023 | - | -153.57%(+17.4%) |
| Dec 2022 | -197.17% | -130.83%(+21.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -108.15%(+16.0%) |
| Jun 2022 | - | -93.23%(+16.5%) |
| Mar 2022 | - | -80.03%(+20.4%) |
| Dec 2021 | -78.36%(-380.7%) | -66.45%(-79.6%) |
| Sep 2021 | - | -326.07%(-252.1%) |
| Jun 2021 | - | 214.36%(+625.2%) |
| Mar 2021 | - | 29.56%(+35.7%) |
| Dec 2020 | 27.92% | 21.78% |
FAQ
- What is Tempest Therapeutics annual return on equity?
- What is the all time high annual ROE for Tempest Therapeutics?
- What is Tempest Therapeutics annual ROE year-on-year change?
- What is Tempest Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly ROE year-on-year change?
What is Tempest Therapeutics annual return on equity?
The current annual ROE of TPST is -110.17%
What is the all time high annual ROE for Tempest Therapeutics?
Tempest Therapeutics all-time high annual return on equity is 27.92%
What is Tempest Therapeutics annual ROE year-on-year change?
Over the past year, TPST annual return on equity has changed by +87.00% (+44.12%)
What is Tempest Therapeutics quarterly return on equity?
The current quarterly ROE of TPST is -187.44%
What is the all time high quarterly ROE for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly return on equity is 214.36%
What is Tempest Therapeutics quarterly ROE year-on-year change?
Over the past year, TPST quarterly return on equity has changed by +190.77% (+50.44%)